[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.197.114. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 1,625
Citations 0
Comment & Response
August 18, 2015

Inferior Vena Cava Filter and Recurrent Pulmonary Embolism

Author Affiliations
  • 1Section of Vascular and Interventional Radiology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
JAMA. 2015;314(7):728-729. doi:10.1001/jama.2015.8009

To the Editor The study by Dr Mismetti and colleagues1 for the Prévention du Risque d’Embolie Pulmonaire par Interruption Cave 2 (PREPIC2) Study Group reinforced some of the findings of the original PREPIC trial2 and discounted others.

As in the PREPIC study, at the 3-month end point, there was no advantage to filter placement in patients with venous thromboembolism receiving anticoagulation.3 This result validates the current recommendations of numerous societies as to the lack of added benefit of an inferior vena cava filter in the treatment of a patient with venous thromboembolism who receives adequate anticoagulation.4

First Page Preview View Large
First page PDF preview
First page PDF preview
×